Charles W. Newton is of 2seventy bio, Inc.. Currently has a direct ownership of 0 shares of TSVT, which is worth approximately $0. The most recent transaction as insider was on May 13, 2025, when has been sold 5,533 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Charles W. Newton Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
5,533 Reduced 100.0%
0 Common Stock
May 13 2025
SELL
Sale (or disposition) back to the issuer
-
17,092 Reduced 75.54%
5,533 Common Stock
Jun 10 2024
BUY
Grant, award, or other acquisition
-
6,025 Added 21.03%
22,625 Common Stock
Mar 20 2024
BUY
Grant, award, or other acquisition
-
16,600 Added 50.0%
16,600 Common Stock

Also insider at

LYEL
Lyell Immunopharma, Inc. Healthcare
CHRS
Coherus BioSciences, Inc. Healthcare
NVAX
NOVAVAX INC Healthcare
CWN

Charles W. Newton

South San Francisco, CA

Track Institutional and Insider Activities on TSVT

Follow 2seventy bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSVT shares.

Notify only if

Insider Trading

Get notified when an 2seventy Bio, Inc. insider buys or sells TSVT shares.

Notify only if

News

Receive news related to 2seventy bio, Inc.

Track Activities on TSVT